AAAAAA

   
Results: 1-9 |
Results: 9
A PHASE-II TRIAL OF CI-980 IN ADVANCED NONSMALL CELL LUNG-CANCER
Authors: VOKES EE ARRIETA R LAD T MASTERS GA HOFFMAN PC ANSARI R SCHUMM P GOLOMB HM
Citation: Ee. Vokes et al., A PHASE-II TRIAL OF CI-980 IN ADVANCED NONSMALL CELL LUNG-CANCER, Annals of oncology, 9, 1998, pp. 380-380
PHASE-II STUDY OF DOXORUBICIN (DOX) AND PACLITAXEL (TAX) GIVEN PRIOR TO STANDARD CISPLATIN (P) AND ETOPOSIDE (E) IN PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER (SCLC)
Authors: MAUER A LAD T HOFFMAN P ARIETA R GABRYS J SCIORTINO D VOKES E
Citation: A. Mauer et al., PHASE-II STUDY OF DOXORUBICIN (DOX) AND PACLITAXEL (TAX) GIVEN PRIOR TO STANDARD CISPLATIN (P) AND ETOPOSIDE (E) IN PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER (SCLC), Annals of oncology, 9, 1998, pp. 655-655
RADIOTHERAPY ALONE COMPARED WITH RADIOTHERAPY AND CHEMOTHERAPY IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS
Authors: REDDY SP LAD T MULLANE M ROSEN F CARROLL R MARKS JE
Citation: Sp. Reddy et al., RADIOTHERAPY ALONE COMPARED WITH RADIOTHERAPY AND CHEMOTHERAPY IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS, American journal of clinical oncology, 18(5), 1995, pp. 376-381
PHASE-II STUDY OF AMONAFIDE IN THE TREATMENT OF PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND THE NECK - AN ILLINOIS-CANCER-CENTER STUDY
Authors: ROSEN F VOKES EE LAD T KIES M WADE J KILTON LJ BLOUGH R FRENCH S MULLANE M BENSON AB
Citation: F. Rosen et al., PHASE-II STUDY OF AMONAFIDE IN THE TREATMENT OF PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND THE NECK - AN ILLINOIS-CANCER-CENTER STUDY, Investigational new drugs, 13(3), 1995, pp. 249-252
RANDOMIZED TRIAL OF LOBECTOMY VERSUS LIMITED RESECTION FOR T1 N0 NON-SMALL-CELL LUNG-CANCER
Authors: HOLMES CE RUCKDESCHEL JC JOHNSTON M THOMAS PA DESLAURIERS J GROVER FL HILL LD FELD R GINSBERG RJ MOUNTAIN CF DZUIBAN S KIELY M MCKNEALLY MF MOORES DWO RAMNES C WAGNER H BUNN P CHU H DIENHART D HAZUKA M KINZIE J SORENSEN J VANCE V BRAUN T HOPEMAN A KANE M RUSS P WHITMAN GJR FALL SM HANSEN DP HENDERSON RH MONCRIEF CL PAULING F SIMS J TELL D WISELYCARR S ABERNATHY CM CLARK DA MCCROSKEY B MOORE G MOORE F MYERS A WHITE M BROOKS RJ BULL M JOHNSON FB NEIMYR M PAQUETTE FR SACCOMANNO G LAD T HERMANSEN K LIEBNER E MCGUIRE WP FRY W STEMPELFELD B ALEXANDER JC BECK J GARCES RM IMPERATO JP KAHANDEKAR J KNOP R LOCKER G MERKEL DE PANELLA JS ROCHESTER D VICTOR TA JOHNSON C JOOB AW ROBINSON P ROSEN S SHIELDS T DOOLEY S TIO FO HOLLAND C TREASURE RL GOTTFRIED B BEDDINGFIELD G BOWER J CHENG D DALY MB LADD WA LEACH C MURPHY K QUINTON R SMITH VC YOUNG ME BLANTON M BRIGGS R GRISHKIN BA HELSEL R JACKSON D JACKSON ME YOUNG R ZALOZNIK A BLOCK K DAIL DH DREIS D GUYTON SW HAFERMANN M HAMMAR SP JOLLY PC MORGAN E SPRINGMEYER S TAYLOR EW WEIDEN PW KNUDSEN N LIVINGSTON RB RUSCH VW GRAFTON C LERICHE J MURRAY N PAGE R GOODMAN GE AYE RW EVANS KG MILLER RR NELEMS B HIGANO C BERGSAGEL D BROWN TC CURTIS J PAYNE D PRINGLE JF QUIRT I STEWARD L WARR D YEOH L BURKES R COOTER N GOLDBERG M MULLEN B SCHMOCKER B HARRIS F ILVES R SINCLAIR JM SPRATT E BAKER M CHAMBERLAIN DW COOPER JD DESANTIS D EVANS WK PATTERSON GA PEARSON FG RITCHIE AC SHEPHERD FA TAYLOR D TODD TRJ WEBSTER J WINTON TL KIRBY TJ LIPA M FRENCH S SUTTON D WARNER E WATERS PF JONES D HOLMES EC SELCH RA SHIPLACOFF J GANZ P SILVERMAN B HASKELL C SADEGHI A WILLIAMS A WOLLMAN J BLOCH JH CORDER MP HERMES K LUKEMAN JM MURPHY A PIANTADOSI S GOODMAN S RUBINSTEIN LV GAIL MH BOSSENGA M LAKE WH LONG S
Citation: Ce. Holmes et al., RANDOMIZED TRIAL OF LOBECTOMY VERSUS LIMITED RESECTION FOR T1 N0 NON-SMALL-CELL LUNG-CANCER, The Annals of thoracic surgery, 60(3), 1995, pp. 615-622
THE COMPARISON OF CAP CHEMOTHERAPY AND RADIOTHERAPY TO RADIOTHERAPY ALONE FOR RESECTED LUNG-CANCER WITH POSITIVE MARGIN OR INVOLVED HIGHESTSAMPLED PARATRACHEAL NODE (STAGE-IIIA) - LCSG-791
Authors: LAD T
Citation: T. Lad, THE COMPARISON OF CAP CHEMOTHERAPY AND RADIOTHERAPY TO RADIOTHERAPY ALONE FOR RESECTED LUNG-CANCER WITH POSITIVE MARGIN OR INVOLVED HIGHESTSAMPLED PARATRACHEAL NODE (STAGE-IIIA) - LCSG-791, Chest, 106(6), 1994, pp. 190000302-190000306
A PROSPECTIVE RANDOMIZED TRIAL TO DETERMINE THE BENEFIT OF SURGICAL RESECTION OF RESIDUAL DISEASE FOLLOWING RESPONSE OF SMALL-CELL LUNG-CANCER TO COMBINATION CHEMOTHERAPY
Authors: LAD T PIANTADOSI S THOMAS P PAYNE D RUCKDESCHEL J GIACCONE G
Citation: T. Lad et al., A PROSPECTIVE RANDOMIZED TRIAL TO DETERMINE THE BENEFIT OF SURGICAL RESECTION OF RESIDUAL DISEASE FOLLOWING RESPONSE OF SMALL-CELL LUNG-CANCER TO COMBINATION CHEMOTHERAPY, Chest, 106(6), 1994, pp. 190000320-190000323
RANDOMIZED PHASE-2 EVALUATION OF PREOPERATIVE RADIATION-THERAPY AND PREOPERATIVE CHEMOTHERAPY WITH MITOMYCIN, VINBLASTINE, AND CISPLATIN INPATIENTS WITH TECHNICALLY UNRESECTABLE STAGE-IIIA AND STAGE-IIIB NONSMALL CELL-CANCER OF THE LUNG - LCSG-881
Authors: WAGNER H LAD T PIANTADOSI S RUCKDESCHEL JC
Citation: H. Wagner et al., RANDOMIZED PHASE-2 EVALUATION OF PREOPERATIVE RADIATION-THERAPY AND PREOPERATIVE CHEMOTHERAPY WITH MITOMYCIN, VINBLASTINE, AND CISPLATIN INPATIENTS WITH TECHNICALLY UNRESECTABLE STAGE-IIIA AND STAGE-IIIB NONSMALL CELL-CANCER OF THE LUNG - LCSG-881, Chest, 106(6), 1994, pp. 190000348-190000354
THE EARLY DETECTION OF 2ND PRIMARY LUNG CANCERS BY SPUTUM IMMUNOSTAINING
Authors: TOCKMAN MS EROZAN YS GUPTA P PIANTADOSI S MULSHINE JL RUCKDESCHEL JC BUKOWSKI RM LAD T ETTINGER DS DESLAURIERS J GINSBERG R KELLY K HOLMES EC MUGGIA F ROTH JA JOHNSTON M MCKNEALLY MF
Citation: Ms. Tockman et al., THE EARLY DETECTION OF 2ND PRIMARY LUNG CANCERS BY SPUTUM IMMUNOSTAINING, Chest, 106(6), 1994, pp. 190000385-190000390
Risultati: 1-9 |